Relmada Therapeutics Inc

NASDAQ:RLMD   3:59:50 PM EDT
18.49
-0.31 (-1.65%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Relmada Therapeutics Inc Stock, NASDAQ:RLMD

2222 Ponce de Leon Boulevard, 3rd floor, Coral Gables, Florida 33134
United States of America
Phone: +1.646.876.3459
Number of Employees: 14

Description

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. It focuses on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist, which is a New Chemical Entity (NCE) that potentially addresses areas of high unmet medical need in the treatment of central nervous system (CNS) diseases and other disorders. The company was founded on May 31, 2012 and is headquartered in Coral Gables, FL.